Aspiriant LLC’s AB InBev BUD Stock Holding History

Aspiriant LLC’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,670	Closed	-$378K	–	287
2023 Q1	$378K	Hold	5,670	–	–	0.02%	198
2022 Q4	$340K	Hold	5,670	–	–	0.02%	203
2022 Q3	$256K	Hold	5,670	–	–	0.01%	223
2022 Q2	$306K	Hold	5,670	–	–	0.01%	208
2022 Q1	$340K	Hold	5,670	–	–	0.02%	212
2021 Q4	$343K	Buy	5,670 +1,000	+21%	+$58.2K	0.02%	220
2021 Q3	$263K	Hold	4,670	–	–	0.02%	205
2021 Q2	$336K	Buy	+4,670	New	+$341K	0.02%	190

Other funds holding BUD

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Aspiriant LLC's BUD Position: Q2 2023 in Review

Aspiriant LLC sold out of AB InBev (BUD) in Q2 2023, closing a stake of 5,670 shares — an estimated $378K sold.

Aspiriant LLC first reported a position in BUD in Q2 2021 and held it in 8 quarters. The position peaked at $378K in Q1 2023. 488 funds tracked by Wall St. Rank hold BUD as of Q2 2023.

Aspiriant LLC reported no remaining AB InBev position as of Q2 2023 after selling out during the quarter.
Aspiriant LLC sold 5,670 AB InBev shares in Q2 2023, an estimated $378K.
Aspiriant LLC first reported a position in AB InBev in Q2 2021 and held it in 8 quarters.
Aspiriant LLC's AB InBev position peaked at $378K in Q1 2023.
488 funds tracked by Wall St. Rank held AB InBev as of Q2 2023.

Based on Aspiriant LLC's 13F filing for Q2 2023, filed 19 Jul 2023.